2 unknown, 1 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Completed 1 |
Follow Cefoperazone: new trials by email Literature Review of Cefoperazone trials Research Report on Cefoperazone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluate Bioequivalence of Burotam (1/1 g/Vial) cefoperazone sodium and sulbactam sodium - Infectious Diseases | Phase 4 | Unknown | Yung Shin Pharm. Ind. Co., Ltd. | 14 | 2022-08-25 | 2023-02-01 |
| Multi-center Clinical Study of Early Antibios of Severe Acute Pancreatitis cefoperazone + metronidazole, oral care by chlorhexidine gluconate, enteral nutrition - Pancreatitis,Acute Necrotizing | Phase 4 | Unknown | Erzhen Chen | 60 | 2012-07-01 | 2013-11-25 |
| A Comparative Phase IV Study Evaluating Efficacy & Safety Of Magnex(Cefoperazone-Sulbactam) In Intraabdominal Infections Magnex (Sulbactam Sodium/Cefoperazone Sodium 1:1) Pfizer Ltd., Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited, Metrogyl (Metronidazole Injection IP) J.B.Chemicals & Pharmaceuticals Ltd. - Infection | Phase 4 | Completed | Pfizer | 307 | 2004-07-01 | 2008-12-02 |
Communicable Diseases (1) · Infections (1) · Pancreatitis, Acute Necrotizing (1)
Erzhen Chen (1) · Pfizer (1) · Yung Shin Pharm. Ind. Co., Ltd. (1)
China (1) · India (1) · Taiwan (1)
En-Qiang Mao, M.D. & Ph.D. (1) · Er-Zhen Chen, M.D. & Ph.D. (1) · Zhi-Tao Yang, M.D. & Ph.D. (1)